385 related articles for article (PubMed ID: 8648668)
1. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Wu X; Liu H; Xiao H; Conway JA; Kappes JC
J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
3. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
Wu X; Liu H; Xiao H; Kim J; Seshaiah P; Natsoulis G; Boeke JD; Hahn BH; Kappes JC
J Virol; 1995 Jun; 69(6):3389-98. PubMed ID: 7745685
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Liu H; Wu X; Xiao H; Conway JA; Kappes JC
J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
[TBL] [Abstract][Full Text] [Related]
5. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
Wu X; Conway JA; Kim J; Kappes JC
J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
[TBL] [Abstract][Full Text] [Related]
6. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
[TBL] [Abstract][Full Text] [Related]
7. Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR
J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741
[TBL] [Abstract][Full Text] [Related]
8. Targeting a foreign protein into virion particles by fusion with the Vpx protein of simian immunodeficiency virus.
Park IW; Sodroski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):341-50. PubMed ID: 8601220
[TBL] [Abstract][Full Text] [Related]
9. Targeting of chrolamphenicol acetyltransferase to human immunodeficiency virus particles via Vpr and Vpx.
Sato A; Isaka Y; Kodama M; Yoshimoto J; Kawauchi S; Kuwata T; Adachi A; Hayami M; Yoshi O; Fujiwara T
Microbiol Immunol; 1995; 39(12):1015-9. PubMed ID: 8789063
[TBL] [Abstract][Full Text] [Related]
10. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm).
Accola MA; Bukovsky AA; Jones MS; Göttlinger HG
J Virol; 1999 Dec; 73(12):9992-9. PubMed ID: 10559313
[TBL] [Abstract][Full Text] [Related]
11. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S
J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364
[TBL] [Abstract][Full Text] [Related]
12. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
Stewart L; Vogt VM
J Virol; 1991 Nov; 65(11):6218-31. PubMed ID: 1717719
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain.
Mahalingam S; Van Tine B; Santiago ML; Gao F; Shaw GM; Hahn BH
J Virol; 2001 Jan; 75(1):362-74. PubMed ID: 11119605
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
16. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
[TBL] [Abstract][Full Text] [Related]
17. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.
Kappes JC; Parkin JS; Conway JA; Kim J; Brouillette CG; Shaw GM; Hahn BH
Virology; 1993 Mar; 193(1):222-33. PubMed ID: 8438567
[TBL] [Abstract][Full Text] [Related]
18. Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a
Benner BE; Bruce JW; Kentala JR; Murray M; Becker JT; Garcia-Miranda P; Ahlquist P; Butcher SE; Sherer NM
J Virol; 2022 Jan; 96(1):e0134921. PubMed ID: 34643428
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
Padow M; Lai L; Fisher RJ; Zhou YC; Wu X; Kappes JC; Towler EM
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1973-80. PubMed ID: 11153080
[TBL] [Abstract][Full Text] [Related]
20. HIV-2 viral protein X association with the GAG p27 capsid protein.
Horton R; Spearman P; Ratner L
Virology; 1994 Mar; 199(2):453-7. PubMed ID: 8122374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
